REPTT is an observational, prospective, multi-country, multicentre and non-interventional registry in which at least 300 patients with Thrombotic thrombocytopenic purpura (TTP) in Spain and Portugal will be evaluated.
The study will be carried out in the context of the usual clinical practice conditions, not imposing restrictions on the participating physician or influencing their normal clinical practice.
Patients with diagnosis of TTP according to International Consensus criteria from centres in Spain and Portugal.
Patients that voluntarily sign the informed consent. For subjects unable to provide informed consent, a fully recognized medical authority may be used according to local laws.
Patients between 0 to 99 years old at the time of diagnosis.
Inability to comply with study procedures and follow-up exams.
Patients with any type of alteration that compromises their ability to grant written informed consent.
Patients that do not consent to participate in the study and do not sign informed consent.
Patients that do not meet the criteria previously mentioned for TTP.